The reverse is also going  to happen, which is that if we use our antibiotics appropriately, we don't necessarily have  to make the investments in new drug development.
No caso contrario sucederá que, se empregamos os antibióticos  axeitadamente, non necesariamente teremos que investir no desenvolvemento de novos fármacos.